Issue 221

29.10.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

NEWLY RELEASED INUSTRIAL HEMP REPORT ONLY AVAVILABLE IN THE IMPACT SERIES: REPORT BUNDLE

Get ahead with Prohibition Partners’ report bundle, The Impact Series. This series of reports analyses how cannabis is disrupting more mainstream and traditional industries, such as food, drinks, beauty, construction and manufacturing, amongst others.

This package of five reports includes digital copies of Prohibition Partners’ Industrial Hemp, Disrupting Petcare, Disrupting Food, Disrupting Drinks and Disrupting Beauty.

BUY LIMITED EDITION BUNDLE »

 


 

FINLAND’S SUPREME COURT ALLOWS CBD IMPORTATION ON A CASE-BY-CASE BASIS

READ MORE »

 

SOCIAL SERVICES IN ARGENTINA COURT ORDERED TO PROVIDE CANNABIS OIL TO EPILEPSY PATIENT

READ MORE »

Europe

Upcoming Event

CANNABIS EUROPA LONDON IS SOLD OUT: STREAMING TICKETS AVAILABLE

Cannabis Europa London is bringing together the best of the European cannabis industry for a day of focused panels, unrivalled networking and pivotal insights right from the source.

Tickets are all sold out, however we’ve ensured that you don’t miss out on this industry defining event by making it available to watch live with a FREE streaming ticket.

REGISTER NOW »

USA

  • New York takes steps toward legalising home cultivation of up to six plants for medical cannabis patients.
  • Minnesota sends out Hemp Acreage and Production Survey to 569 hemp farmers, to improve processes and policies.
  • An Arkansas Democrat launches a campaign to place cannabis legislation on the ballot in 2022.
  • Nevada records US$1 billion in cannabis sales from June 2020 to June 2021, according to the Department of Taxation.
  • Rhode Island prepares for cannabis legalisation as outstanding regulatory issues are being resolved.
  • Jushi Holdings to acquire Nature’s Remedy by drawing funds from its joint venture with Sundial Growers.
  • Washington D.C. cannabis bill will no longer include Harris Rider, allowing the state to regulate and tax cannabis.

UPCOMING EVENT

SOMAÍ ANNOUNCED AS GOLD SPONSORS OF CANNABIS EUROPA LONDON

Cannabis Europa is happy to announce SOMAÍ Pharmaceuticals, a large-scale manufacturer of cannabis products, as a Gold Sponsor of Cannabis Europa London.

SOMAÍ Pharmaceuticals is focused on the creation of unique cannabis formulations for the EU market, developed and manufactured in line with EU GMP regulations for pharmaceutical products. SOMAÍ concentrates on the highest quality medical-grade pharmacological applications, produced in tandem with an experienced scientific team from the USA.

FIND OUT MORE »

CANADA

  • Canada records 44% increase in cannabis sales, reaching C$375 million in the month of August.
  • Creso Pharma enters the CBD sports market after bolstering its North American presence with acquisition of ImpACTIVE.
  • High Tide continues Canadian expansion, opening additional Canna Cabana stores in Saskatchewan and Ontario.
  • Ayurcann enters into a patient-referral agreement with The Herb Clinic, providing it with access to 4,000 patients.
  • A study finds the prevalence for vaping cannabis among Canadian teenagers has doubled since 2013.
  • Xebra Brands announces its listing on Frankfurt Stock Exchange, its second international listing after the CSE.

LATAM & CARIBBEAN

WEBINAR

STATE OF PLAY SESSION WITH GAVIN OGILVIE AND JAY ROSENTHAL

In this State of Play Session, we will be gaining insights from the CEO of one of the fastest growing cannabis enterprises in Europe, Always Pure Organics.

Join us on 3 November for an in-depth fireside chat with Gavin Ogilvie of Always Pure Organics and Jay Rosenthal of Business of Cannabis as they discuss the future of the cannabis market in Europe.

RESERVE YOUR SEAT »

APAC

  • Little Green Pharma reports an all-time monthly high revenue for September, reaching AU$1.39 million.
  • A Thai resort adds cannabis-infused treatments to its menu in preparation for the return of tourists to the country.
  • Epsilon enters into an exclusive partnership with the Valens Company, with the aim of being profitable in 2022.
  • New Zealand government to help boost the country’s medical cannabis industry with NZ$760,000 in funding.
  • Cannim signs a two-year deal with Epsilon to become its Australian GMP manufacturing partner.

AFRICA & MIDDLE EAST

Read the stories that shape the cannabis industry